CPT 38220: Bone Marrow Aspiration for Diagnostic Evaluation
CPT code 38220 represents a diagnostic bone marrow aspiration, in which a long, large-bore needle is inserted into the sternum or pelvic bone to aspirate marrow for laboratory analysis. This code is used nationally to capture a common hematologic diagnostic procedure essential for evaluating marrow disorders such as anemias, leukemias, and myelodysplastic syndromes. Accurate coding supports appropriate claims processing and clinical documentation across inpatient and outpatient settings.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find an overview of clinical context and operative setting for the procedure, comparisons and benchmark considerations across major commercial payers and Medicare, and guidance on closely related codes used when biopsy or combined aspiration/biopsy services are performed. The publication highlights common claim relationships between 38220 and related CPT codes for bone marrow biopsy and combined procedures, and outlines typical diagnostic indications tied to the service.
This material is intended for billing managers, coding professionals, and clinical staff seeking a concise national overview of CPT code 38220, including service definitions, payer coverage context, and where to look for differences in coding and reimbursement practices among major payers.
Customize your policy alerts
Sign up for cpt 38220 policy alerts
Get alerted when payer policies referencing 38220 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 38220 describes a bone marrow aspiration performed for diagnostic purposes. The procedure involves insertion of a long, large-bore needle into the sternum or pelvic bone to aspirate bone marrow tissue for laboratory evaluation.
Service type: Diagnostic invasive procedure
Typical site of service: Hospital inpatient or outpatient setting, ambulatory surgery center, or procedure suite where sterile invasive diagnostic procedures are performed
National Reimbursement Benchmarks
Nationally, Medicare’s mean rate sits at $174.30 while BUCA’s average commercial mean is $387.50, showing BUCA pays roughly $213.20 more on average than Medicare for CPT 38220. That divergence highlights a sizable split between Medicare reimbursement and certain commercial contracts, with BUCA notably above both the overall commercial cohort means and Medicare.
Dispersion varies across payers: Blue Cross Blue Shield has one of the widest interquartile ranges at $231.60 (P75 $674.90 minus P25 $443.00), followed by UnitedHealth Group at $159.10 (P75 $292.40 minus P25 $136.30). Aetna displays a tighter spread of $101.40 (P75 $139.40 minus P25 $38.00), and Cigna’s spread is $164.20 (P75 $266.70 minus P25 $102.50). BUCA’s IQR is $192.70 (P75 $485.40 minus P25 $292.70). These differences signal varied variability in contracted rates across payers.